Haleos Labs Limited Files Annual Confirmation for Approved Reclassification Under SEBI Regulation 31A
Haleos Labs Limited filed annual confirmation on April 8, 2026, with stock exchanges regarding two former promoters who were reclassified to public category under SEBI Regulation 31A in April 2022. Mr. Suresh Babu Potluri and Mr. Hari Kishore Potluri, who currently hold no shares, have confirmed continued compliance with regulatory requirements including maintaining shareholding below 10% and not exercising control over company affairs.

*this image is generated using AI for illustrative purposes only.
Haleos Labs Limited has submitted its annual confirmation to stock exchanges regarding the continued compliance of reclassified former promoters with SEBI regulations. The company filed the confirmation on April 8, 2026, with both BSE Limited and National Stock Exchange of India Limited.
Reclassification Details
The annual confirmation relates to the reclassification application that was approved by both stock exchanges on April 13, 2022. Under this approval, two former promoters were reclassified from promoter category to public category in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Parameter | Details |
|---|---|
| Filing Date | April 8, 2026 |
| Original Approval Date | April 13, 2022 |
| Regulation | SEBI Regulation 31A |
| Reclassified Persons | 2 former promoters |
Former Promoters Status
The confirmation covers two individuals who were reclassified to public category:
| Sr. No. | Name of Erstwhile Promoters | Current Shareholding | % of Holding |
|---|---|---|---|
| 1 | Mr. Suresh Babu Potluri | - | - |
| 2 | Mr. Hari Kishore Potluri | - | - |
Both former promoters currently hold no shares in the company, as indicated by the dash entries in their shareholding status.
Compliance Confirmations
Both Mr. Suresh Babu Potluri and Mr. Hari Kishore Potluri have provided individual declarations dated April 5, 2026, confirming their continued compliance with regulatory requirements. Their confirmations include several key compliance points:
- Do not hold more than 10% of total voting rights in the company
- Do not exercise control over company affairs, directly or indirectly
- Do not have special rights through formal or informal arrangements
- Are not represented on the Board of Directors
- Do not act as key managerial persons of the company
- Are not wilful defaulters as per RBI Guidelines
- Are not fugitive economic offenders
- Have no pending regulatory action against them
Regulatory Framework
The individuals must continue complying with specific sub-clauses of Regulation 31A(3) at all times from the reclassification date. Additionally, they must comply with certain conditions for a period of not less than 3 years from the date of reclassification. Failure to maintain compliance would result in their reclassification as promoters or persons belonging to the promoter group.
Company Information
Haleos Labs Limited, formerly known as SMS Lifesciences India Limited, is headquartered in Hyderabad with its registered office at Plot No. 19-III, Rod No. 71, Jubilee Hills. The company secretary Trupti Ranjan Mohanty signed the filing documents on behalf of the company.
Historical Stock Returns for Haleos
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.05% | +2.03% | +1.04% | +14.10% | +1.89% | +130.40% |
What strategic changes might Haleos Labs pursue now that former promoters have maintained zero shareholding for four years since reclassification?
How could the successful promoter reclassification impact Haleos Labs' ability to attract new institutional investors or strategic partners?
Will other pharmaceutical companies follow similar promoter reclassification strategies to improve corporate governance ratings?


































